Clinical Trial Update: Role of Co-trimoxazole in Severe COVID-19 Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigates the role of co-trimoxazole in severe COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Coronavirus 2 Infection

Drugs mentioned

• Co-trimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Covid19, Severe COVID-19 Patients | Phase 2 | Status: UNKNOWN